Global Deferiprone Market Study 2015-2025, by Segment (Tablet, Oral Solution, Capsule), by Market (Transfusional Iron Overload, NTDT Caused Iron OverloadOral Solution), by Company (Apotex, Cipla)
ReportPage
Report ID
16434
Published Date
20-Sep
No of Report Page
68
Report Category
Chemicals and Materials
Editor's Rating
US $3,600.00
US $3,600.00
US $1,800.00

  • Report Details 
    Snapshot
    
Deferiprone is an orally bioavailable bidentate ligand with iron chelating activity.1 It binds to iron in a 3:1 (ligand:iron) molar ratio and, thereby, is able to remove excess iron from the body. Deferiprone has been investigated for clinical use in diseases of systemic iron overload
    
The global Deferiprone market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025
    More...
  • Table Of Content 
    Table of Content
    
1 Industry Overview
    
    1.1 Deferiprone Industry
    
        1.1.1 Overview
    
        1.1.2 Products of Major Companies
    
    1.2 Market Segment
    
        1.2.1 Industry Chain
    
        1.2.2 Consumer Distribution
    
    1.3 Price & Cost Overview
    
2 Deferiprone Market by Type
    
    2.1 By Type
    
       2.1.1 Tablet
    
       2.1.2 Oral Solution
    
       2.1.3 Capsule
    
    2.2 Market Size by Type
    
    2.3 Ma
    More...
  • Inquiry Before Buying
    Inquiry Before Buying -
  • Request Sample
    Request For Sample
portalmarketdeskus
 
Office No 8, 3rd Floor, Aston Plaza, Katraj - Ambegaon Road, Ambegaon BK, Pune, Maharashtra, India. Pin- 411046
Navigation : -
Connect with Us : -
Secured Payment Options : -